Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)
Dexcom (DXCM) posted quarterly Non-Current Deffered Revenue of $600000.0 for Q4 2012, up 100.0% year-over-year from $300000.0 in Q1 2012, and up 5.45% quarter-over-quarter from $569000.0 in Q3 2012.
Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012) Analysis & Trends
Dexcom (DXCM) has reported Non-Current Deffered Revenue for 2 consecutive years, with $600000.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Non-Current Deffered Revenue rose 100.0% year-over-year to $600000.0; the TTM figure through Dec 2012 stood at $600000.0 (up 100.0% YoY), while the FY2012 annual figure was $600000.0, up 100.0% from the prior year.
- Non-Current Deffered Revenue advanced to $600000.0 in Q4 2012 per DXCM's latest filing, from $569000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $834000.0 in Q1 2012 and bottomed at $300000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 702,000.00 |
| Mar 31, 2012 | 834,000.00 |
| Dec 31, 2011 | 300,000.00 |